Wypełniacze skórne
YVOIRE pozycji w ofercie ALLPARA do użytku profesjonalnego, kupowanych bezpośrednio i z certyfikatem przy każdej wysyłce.
Oznakowanie CE
SKU 11239
Yvoire Y-Solution 360
Dostępny
Objętość
1 x 1 mL
Laboratorium
LG Chem
Pochodzenie
Korea Południowa
Wskazanie
Anti-ageing correction with flexible projection
Obszary zabiegowe
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
Najważniejsze zalety: Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Zastosowanie profesjonalne
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
Obszary zabiegowe
- Face
Profil pacjenta
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
Jak działa Yvoire Y-Solution 360
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty YVOIRE od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.
Najczęściej zadawane pytania
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from the 540 and 720?
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
Więcej od LG Chem
Alternatywy dla kliniki
Mezoterapia
Skin boostery
/ Ostatnio oglądane
Kontynuuj przeglądanie
Yvoire Y-Solution 360
Dostępny
Oznakowanie CE
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.
Najważniejsze zalety: Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
- Built on the manufacturer's S-HICE cross-linking process
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
- Supplied with two Terumo thin-wall 29G needles
Wskazania i zastosowanie profesjonalne
Główne wskazania
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Zastosowanie profesjonalne
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.
Obszary zabiegowe
- Face
Profil pacjenta
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
Jak działa Yvoire Y-Solution 360
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Dlaczego warto zamawiać w Allpara
Allpara oferuje oryginalne, sprawdzone produkty YVOIRE z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.
Najczęściej zadawane pytania
What is in Yvoire Y-Solution 360?
Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
How does Yvoire Y-Solution 360 differ from the 540 and 720?
The 360 is 12 mg/mL with 29G needles. The 540 and 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.
Więcej od LG Chem
Zobacz laboratorium →* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).